Literature DB >> 3110677

Plasma met-enkephalin and leu-enkephalin in chronic renal failure.

C Zoccali, M Ciccarelli, F Mallamaci, Q Maggiore, M Lotti, G C Zucchelli.   

Abstract

Plasma met-enkephalin and leu-enkephalin has been measured in a group of 28 patients with chronic renal failure, to discover whether these opioids are affected by standard haemodialysis and haemofiltration. Met-enkephalin was markedly higher (P less than 0.001) in uraemic patients than in a group of 13 normal subjects, and was directly related to plasma creatinine (r = 0.60; P less than 0.01) and to plasma urea (r = 0.36; P = 0.06). In contrast, leu-enkephalin was suppressed in uraemic patients (P less than 0.001). Met-enkephalin fell slightly but significantly (P less than 0.02) after both haemodialysis and haemofiltration; however, on average it remained at concentrations four times higher than normal. No changes in plasma leu-enkephalin were observed after haemodialysis and haemofiltration. The cause(s) of the altered plasma concentrations of these opioid substances remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110677

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD.

Authors:  Christina-Alexandra Schulz; Anders Christensson; Ulrika Ericson; Peter Almgren; George Hindy; Peter M Nilsson; Joachim Struck; Andreas Bergmann; Olle Melander; Marju Orho-Melander
Journal:  J Am Soc Nephrol       Date:  2016-07-08       Impact factor: 10.121

Review 2.  A systematic review of central sleep apnea in adult patients with chronic kidney disease.

Authors:  Gaurav Nigam; Charu Pathak; Muhammad Riaz
Journal:  Sleep Breath       Date:  2016-01-27       Impact factor: 2.816

3.  Plasma Proenkephalin and Poor Long-Term Outcome in Renal Transplant Recipients.

Authors:  Lyanne M Kieneker; Oliver Hartmann; Joachim Struck; Andreas Bergmann; Ron T Gansevoort; Michel M Joosten; Else van den Berg; Rudolf A de Boer; Stephan J L Bakker
Journal:  Transplant Direct       Date:  2017-07-07

Review 4.  Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.

Authors:  Raymond Vanholder; Anneleen Pletinck; Eva Schepers; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2018-01-08       Impact factor: 4.546

Review 5.  Immune Dysfunction in Uremia 2020.

Authors:  Gerald Cohen
Journal:  Toxins (Basel)       Date:  2020-07-05       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.